Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide.

Beijing, China (IFB = Insulin Facility Beijing) and Frankfurt, Germany (IFF = Insulin Facility Frankfurt) have been selected as the locations for the two facilities.

The new production facilities will be designed as fully automated, environmentally friendly, and state-of-the-art biologics facilities that consider the specific process requirements of all insulins.

We are looking for 4 Leads for the workstreams Upstream and Downstream for the following focus areas:

- USP Lead: Upstream / Fermentation

- MSP Lead: Midstream / cell harvest

- DSP Lead I: Downstream I / High Purification, Chromatography

- DSP Lead II : Downstream II / Isolation and Drying

They will report to the respective department...